Exodus Point Capital Management, LP 10x Genomics, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 289,211 shares of TXG stock, worth $6.53 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
289,211
Previous 165,732
74.51%
Holding current value
$6.53 Million
Previous $6.22 Million
9.57%
% of portfolio
0.04%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding TXG
# of Institutions
284Shares Held
96.2MCall Options Held
162KPut Options Held
107K-
Vanguard Group Inc Valley Forge, PA10.2MShares$230 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.31MShares$210 Million1.65% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$144 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.15MShares$139 Million1.4% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.14MShares$139 Million0.09% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $2.15B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...